|
|
|
| Clinial analysis of octreotide combined with omeprazole sodium in treating hepatocirrhosis with upper gastrointestinal bleeding |
| ZHOU Qing-mei |
| Department of Gerato1ogy,Peop1e’s Hospita1 of Ganzhou City in Jiangxi Province,Ganzhou 341000,China |
|
|
|
|
Abstract Objective To exp1ore the c1inica1 effect of octreotide combined with omeprazo1e sodium in treating hepatocirrhosis with upper gastrointestina1 b1eeding. Methods 56 hepatocirrhosis with upper gastrointestina1 b1eeding patients from Ju1y 2013 to Ju1y 2014 of our hospita1 were retrospective1y ana1yzed.Patients were divided into observation group and contro1 group according to their drug use wi11,and each group was 28 cases.A11 patients of two groups were given genera1 routine treatment.Patients in observation group were given octreotide combined with omeprazo1e sodium,and patients in contro1 group were given routine treatment 1iked gastrointestina1 decompression,fasting, infusion and nutrition support.The treatment effects in two groups were counted.The c1inica1 index inc1uded b1eeding time,hospita1 stay,recurrent b1eeding rate and the incidence rate of adverse effects between two groups were compared. Results The effective rate was 92.9% in observation group,obvious higher than that was 78.6% in contro1 group,and the difference was statistica1 significance （P＜0.05).The averge b1eeding time,averge hospita1 stay and recurrent b1eeding rate in observation group was better than that of contro1 group,and the difference was statistica1 significance （P＜0.05).The incidence rate of adverse effects was 7.1% in observation group,1ower than that was 25.0% in contro1 group,and the difference was statistica1 significance （P＜0.05). Conclusion Octreotide combined with omeprazo1e sodium in treating hepatocirrhosis with upper gastrointestina1 b1eeding has good c1inica1 effects.It can he1p patients to stop b1eeding quick1y,short the hospita1 stay and recurrent b1eeding rate of patients and have 1ow incidence rate of adverse effects.It is worth to popu1arize.
|
|
|
|
|
|
| [1] |
胡又非.奥曲肽联合奥美拉唑治疗肝硬化合并上消化道出血疗效分析[J].医学理论与实践，2013，26（12）：1608-1609.
|
| [2] |
刘建华，朱芬芳.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血疗效观察[J].白求恩医学杂志，2014，12（1）：21-23.
|
| [3] |
黎潜，李小婷，蓝建.奥美拉唑联合凝血酶对上消化道出血的疗效分析[J].海峡药学，2015，27（5）：142-143.
|
| [4] |
安启娴.生长抑素联合奥美拉唑治疗肝硬化性消化道出血的临床疗效观察[J].医药论坛杂志，2014，35（11）：81-85.
|
| [5] |
李红星.奥曲肽联合普莱洛尔治疗肝硬化上消化道出血的效果分析[J].中外医学研究，2014，12（20）：8-9.
|
| [6] |
李帮永，程宇.46例奥曲肽联合奥美拉唑治疗上消化道出血的疗效分析[J].大家健康，2015，9（4）：162.
|
| [7] |
米德富.奥曲肽联合奥美拉唑治疗肝硬化合并上消化道出血的疗效观察[J].大家健康，2013，7（12）：68.
|
| [8] |
刘文挺.奥曲肽联合奥美拉唑治疗肝硬化合并上消化道出血的疗效分析[J].白求恩军医学院学报，2013，11（3）：233-234.
|
| [9] |
黄小娟.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的疗效观察[J].中国现代药物应用，2014，8（12）：100-101.
|
| [10] |
段连强，杨冬梅.奥曲肽联合奥美拉唑治疗肝硬化并上消化道出血的临床研究[J].临床医学工程，2012，19（1）：55-56.
|
| [11] |
黄关盛.奥曲肽联合奥美拉唑钠治疗肝硬化合并上消化道出血的疗效分析[J].临床合理用药杂志，2015，8（1C）：49-50.
|
| [12] |
沈桂生.奥曲肽联合奥美拉唑治疗肝硬化并发非静脉曲张上消化道出血39例疗效观察[J].社区医学杂志，2010，8（8）：26-27.
|
| [13] |
陈敏锋，邓启明，林颖华.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血疗效的Meta分析[J].中国当代医药，2013，20（14）：167-169.
|
| [14] |
唐艳霞.联合应用奥曲肽和奥美拉唑治疗肝硬化上消化道大出血的临床疗效分析[J].当代医药论丛，2015，13（1）：186-187.
|
| [15] |
张丽丽.奥曲肽联合奥美拉唑治疗肝硬化合并上消化道出血50例疗效观察[J].中国伤残医学，2014，22（11）：159.
|
|
|
|
